Literature DB >> 15174517

Primary dural mucosa-associated lymphoid tissue-type lymphoma: case report and review of the literature.

M Rottnek1, J Strauchen, F Moore, S Morgello.   

Abstract

A 47-year-old Hispanic male presented with visual field disturbances, memory impairment, and a seizure. CT and MRI were consistent with meningioma. Both neurologic exam and routine laboratory tests were within normal limits. The patient underwent craniotomy and subtotal resection of the tumor. On H&E, the lesion was composed of a lymphoid mass with well-defined irregularly shaped follicles surrounded by a monomorphic population of small lymphocytes. Marginal zones stained for B-cell markers, CD20 and CD79a, one T-cell marker, CD43, and kappa light chains. While other markers did not stain the majority of tumor cells, they did identify other lymphoid and plasma cell elements. A diagnosis of marginal zone B-cell lymphoma of dura, mucosa-associated lymphoid tissue (MALT)-type (extranodal) was made. MALT-type lymphomas are unusual in the nervous system; this is the first such case reported in a male and serves to emphasize the wide diversity of presentation of a neoplasm originally described in the GI tract and thus far described in the CNS only in females.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15174517     DOI: 10.1023/b:neon.0000024704.70250.42

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  19 in total

Review 1.  Primary low-grade B-cell lymphoma of mucosa-associated lymphoid tissue of the dura mimicking the presentation of an acute subdural hematoma. Case report and review of the literature.

Authors:  Pablo Goetz; Jesus Lafuente; Tomas Revesz; Malcolm Galloway; Ahmet Dogan; Neil Kitchen
Journal:  J Neurosurg       Date:  2002-03       Impact factor: 5.115

2.  Primary extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type in the CNS.

Authors:  T Itoh; M Shimizu; K Kitami; K Kamata; K Mitsumori; M Fujita; A Ohnishi; K Nagashima
Journal:  Neuropathology       Date:  2001-09       Impact factor: 1.906

3.  Primary low-grade B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) arising in dura.

Authors:  N Kambham; Y Chang; A Y Matsushima
Journal:  Clin Neuropathol       Date:  1998 Nov-Dec       Impact factor: 1.368

4.  Marginal zone lymphoma (low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type) of skin and subcutaneous tissue: a study of 15 patients.

Authors:  E M Bailey; J A Ferry; N L Harris; M C Mihm; J O Jacobson; L M Duncan
Journal:  Am J Surg Pathol       Date:  1996-08       Impact factor: 6.394

5.  Primary low-grade B-cell lymphoma of the dura: a mucosa associated lymphoid tissue-type lymphoma.

Authors:  S Kumar; D Kumar; E P Kaldjian; S Bauserman; M Raffeld; E S Jaffe
Journal:  Am J Surg Pathol       Date:  1997-01       Impact factor: 6.394

6.  Breast lymphoma. A B-cell spectrum including the low grade B-cell lymphoma of mucosa associated lymphoid tissue.

Authors:  A R Mattia; J A Ferry; N L Harris
Journal:  Am J Surg Pathol       Date:  1993-06       Impact factor: 6.394

7.  Primary B-cell lymphoma of salivary glands and its relationship to myoepithelial sialadenitis.

Authors:  E Hyjek; W J Smith; P G Isaacson
Journal:  Hum Pathol       Date:  1988-07       Impact factor: 3.466

8.  Primary low-grade hepatic B-cell lymphoma of mucosa-associated lymphoid tissue (MALT)-type.

Authors:  P G Isaacson; P M Banks; P V Best; S P McLure; H K Muller-Hermelink; J I Wyatt
Journal:  Am J Surg Pathol       Date:  1995-05       Impact factor: 6.394

9.  Primary pulmonary lymphoma: a re-appraisal of its histogenesis and its relationship to pseudolymphoma and lymphoid interstitial pneumonia.

Authors:  B J Addis; E Hyjek; P G Isaacson
Journal:  Histopathology       Date:  1988-07       Impact factor: 5.087

Review 10.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

Authors:  N L Harris; E S Jaffe; H Stein; P M Banks; J K Chan; M L Cleary; G Delsol; C De Wolf-Peeters; B Falini; K C Gatter
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

View more
  7 in total

Review 1.  Multimodality imaging of primary CNS lymphoma in immunocompetent patients.

Authors:  S Partovi; S Karimi; J K Lyo; A Esmaeili; J Tan; L M Deangelis
Journal:  Br J Radiol       Date:  2014-04       Impact factor: 3.039

2.  Dural MALT lymphoma with disseminated disease.

Authors:  Kelly Matmati; Nabil Matmati; Yusuf A Hannun; Zoran Rumboldt; Sunil Patel; John Lazarchick; Robert Stuart; Pierre Giglio
Journal:  Hematol Rep       Date:  2010-12-03

Review 3.  Update on extranodal lymphomas. Conclusions of the Workshop held by the EAHP and the SH in Thessaloniki, Greece.

Authors:  E Campo; A Chott; M C Kinney; L Leoncini; C J L M Meijer; C S Papadimitriou; M A Piris; H Stein; S H Swerdlow
Journal:  Histopathology       Date:  2006-04       Impact factor: 5.087

4.  Modern techniques of magnetic resonance in the evaluation of primary central nervous system lymphoma: contributions to the diagnosis and differential diagnosis.

Authors:  Antonio José da Rocha; Bruno Vasconcelos Sobreira Guedes; Talita Maira Bueno da Silveira da Rocha; Antonio Carlos Martins Maia Junior; Carlos Sérgio Chiattone
Journal:  Rev Bras Hematol Hemoter       Date:  2015-12-31

Review 5.  Rare central nervous system lymphomas.

Authors:  Furqaan Ahmed Kaji; Nicolás Martinez-Calle; Vishakha Sovani; Christopher Paul Fox
Journal:  Br J Haematol       Date:  2022-03-16       Impact factor: 8.615

Review 6.  A Rare Case of Composite Dural Extranodal Marginal Zone Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

Authors:  Mark Bustoros; Benjamin Liechty; David Zagzag; Cynthia Liu; Timothy Shepherd; Deborah Gruber; Bruce Raphael; Dimitris G Placantonakis
Journal:  Front Neurol       Date:  2018-04-24       Impact factor: 4.003

7.  Primary Dural Lymphoma Mimicking En Plaque Cerebellopontine Angle Meningioma.

Authors:  Mei Xu; Ashish Bains; Yuan Rong
Journal:  Case Rep Pathol       Date:  2021-07-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.